Catalytic Impact Foundation

Catalytic Impact Foundation (CIF) accelerates life science and healthcare innovations by funding early-stage companies addressing critical unmet medical needs. It deploys philanthropic capital with venture capital discipline, bridging the "Valley of Death" to advance promising scientific breakthroughs. This approach ensures transformative, life-sustaining technologies reach commercialization and patients.

CIF launched in 2015, established through support from its founding donor, Resonance Philanthropies. The organization formed from the insight that much health research stalls without early-stage commercialization funding. CIF created an investment vehicle to deploy philanthropic capital, facilitating the vital progression of innovations from laboratory discovery to clinical application.

The foundation directly benefits nascent life science companies and patients facing critical medical challenges. CIF’s vision is to generate significant health impact through strategic investments in early-stage ventures, rapidly delivering essential innovations. Its "regenerative philanthropy" model ensures continuous funding, advancing technologies to improve global health outcomes.